Smith & Nephew Doubles Down on Medidata

May 1, 2019

Applied Clinical Trials

Medidata has announced that medical technology business Smith & Nephew has consolidated all of its global studies on the Medidata Rave Clinial Cloud. The company expanded its use of Rave clinical solutions and will leverage Medidata Managed Services to design and implement studies globally.

By adopting the Medidata Clinical Cloud, Smith & Nephew has created a seamless data flow from electronic data capture (EDC) to clinical trial management system (CTMS) on a single platform. This simplifies trial oversight, providing clinical operations teams with easy access and visualization of data to understand enrollment and progress of a clinical trial.

Medidata's data-driven CTMS ensures that Smith & Nephew can grow its study portfolio by breaking down data silos, allowing teams to focus on oversight activities that are critical to the success of a trial. With this new functionality clinical operations teams can:

  • Enter data once and find, access, and reuse EDC data whenever necessary

  • Eliminate costly integrations, duplicate data entry, data reconcilitation and manual tracking activities

  • Access data in real time with a single sign on

"Our expanded partnership with Medidata will establish a consistent, unified approach to manage all our clinical trials as we expand our portfolio of advanced medical products to better the lives of patients around the world," said Andy Weymann, chief medical officer, Smith & Nehphew.

Smith & Nephew will work with Medidata's managed services team to design and build studies in the areas of orthopedics, sports medicine, and advanced wound management.

For more information, go to www.medidata.com